{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:11:16Z","timestamp":1789607476480,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS118558"],"award-info":[{"award-number":["RF1NS118558"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM148326"],"award-info":[{"award-number":["P20GM148326"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM148326"],"award-info":[{"award-number":["P20GM148326"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ABA-25-1376140"],"award-info":[{"award-number":["ABA-25-1376140"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ABA-25-1376140"],"award-info":[{"award-number":["ABA-25-1376140"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG080589"],"award-info":[{"award-number":["R01AG080589"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR001997"],"award-info":[{"award-number":["TL1TR001997"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68921-3","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:24:43Z","timestamp":1769750683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clonal expansion of cytotoxic CD8\u207a T cells in lecanemab-associated ARIA"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-7586","authenticated-orcid":false,"given":"Lance A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil V.","family":"Pallerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Ezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea M.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah J.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-6400","authenticated-orcid":false,"given":"Linda J.","family":"Van Eldik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-4696","authenticated-orcid":false,"given":"David W.","family":"Fardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3401-911X","authenticated-orcid":false,"given":"Greg E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-0049","authenticated-orcid":false,"given":"Josh M.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"68921_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388, 9\u201321 (2023).","journal-title":"N Engl J Med"},{"key":"68921_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig, L. S. et al. Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimers Res Ther 16, 105 (2024).","journal-title":"Alzheimers Res Ther"},{"key":"68921_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings, J. et al. Lecanemab: Appropriate Use Recommendations. J Prev Alzheimers Dis 10, 362\u2013377 (2023).","journal-title":"J Prev Alzheimers Dis"},{"key":"68921_CR4","unstructured":"Kane, M. in Medical Genetics Summaries (eds V. M. Pratt et al.) (2012)."},{"key":"68921_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3174\/ajnr.A8469","volume":"46","author":"PM Cogswell","year":"2025","unstructured":"Cogswell, P. M. et al. Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities. American Journal of Neuroradiology 46, 24\u201332 (2025).","journal-title":"American Journal of Neuroradiology"},{"key":"68921_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc2215148","volume":"388","author":"NJ Reish","year":"2023","unstructured":"Reish, N. J. et al. Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke. N Engl J Med 388, 478\u2013479 (2023).","journal-title":"N Engl J Med"},{"key":"68921_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43933-5","volume":"14","author":"E Solopova","year":"2023","unstructured":"Solopova, E. et al. Fatal iatrogenic cerebral beta-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer\u2019s disease. Nat Commun 14, 8220 (2023).","journal-title":"Nat Commun"},{"key":"68921_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.14283\/jpad.2024.159","volume":"11","author":"LBE Shields","year":"2024","unstructured":"Shields, L. B. E. et al. Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center. J Prev Alzheimers Dis 11, 1549\u20131562 (2024).","journal-title":"J Prev Alzheimers Dis"},{"key":"68921_CR9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","volume":"31","author":"L van Olst","year":"2025","unstructured":"van Olst, L. et al. Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease. Nature Medicine 31, 1604\u20131616 (2025).","journal-title":"Nature Medicine"},{"key":"68921_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708\u2013712 (1999).","journal-title":"Nature"},{"key":"68921_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15, 486\u2013499 (2015).","journal-title":"Nat Rev Immunol"},{"key":"68921_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"68921_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"68921_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05937-3","volume":"14","author":"J Cao","year":"2023","unstructured":"Cao, J. et al. Effects of altered glycolysis levels on CD8(+) T cell activation and function. Cell Death Dis 14, 407 (2023).","journal-title":"Cell Death Dis"},{"key":"68921_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"32","author":"AF McGettrick","year":"2020","unstructured":"McGettrick, A. F. & O\u2019Neill, L. A. J. The Role of HIF in Immunity and Inflammation. Cell Metab 32, 524\u2013536 (2020).","journal-title":"Cell Metab"},{"key":"68921_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani, J. A. & Smyth, M. J. Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol 2, 735\u2013747 (2002).","journal-title":"Nat Rev Immunol"},{"key":"68921_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ni1268","volume":"6","author":"AM Intlekofer","year":"2005","unstructured":"Intlekofer, A. M. et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6, 1236\u20131244 (2005).","journal-title":"Nat Immunol"},{"key":"68921_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-10-21","volume":"10","author":"E Ingley","year":"2012","unstructured":"Ingley, E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal 10, 21 (2012).","journal-title":"Cell Commun Signal"},{"key":"68921_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","volume":"13","author":"P Menten","year":"2002","unstructured":"Menten, P., Wuyts, A. & Van Damme, J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13, 455\u2013481 (2002).","journal-title":"Cytokine Growth Factor Rev"},{"key":"68921_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"68921_CR21","doi-asserted-by":"publisher","unstructured":"Kasmani, M. Y. et al. Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection. J Exp Med 220 https:\/\/doi.org\/10.1084\/jem.20220679 (2023).","DOI":"10.1084\/jem.20220679"},{"key":"68921_CR22","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos, J. et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain 141, 2066\u20132082 (2018).","journal-title":"Brain"},{"key":"68921_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","volume":"10","author":"BI Pereira","year":"2019","unstructured":"Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition. Nat Commun 10, 2387 (2019).","journal-title":"Nat Commun"},{"key":"68921_CR24","doi-asserted-by":"publisher","unstructured":"Jordao, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363 https:\/\/doi.org\/10.1126\/science.aat7554 (2019).","DOI":"10.1126\/science.aat7554"},{"key":"68921_CR25","doi-asserted-by":"publisher","first-page":"726421","DOI":"10.3389\/fimmu.2021.726421","volume":"12","author":"EN Goddery","year":"2021","unstructured":"Goddery, E. N. et al. Microglia and Perivascular Macrophages Act as Antigen Presenting Cells to Promote CD8 T Cell Infiltration of the Brain. Front Immunol 12, 726421 (2021).","journal-title":"Front Immunol"},{"key":"68921_CR26","doi-asserted-by":"publisher","first-page":"e56999","DOI":"10.1371\/journal.pone.0056999","volume":"8","author":"PA Romagnoli","year":"2013","unstructured":"Romagnoli, P. A., Premenko-Lanier, M. F., Loria, G. D. & Altman, J. D. CD8 T cell memory recall is enhanced by novel direct interactions with CD4 T cells enabled by MHC class II transferred from APCs. PLoS One 8, e56999 (2013).","journal-title":"PLoS One"},{"key":"68921_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7, 678\u2013689 (2007).","journal-title":"Nat Rev Immunol"},{"key":"68921_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 in T cell function. Exp Cell Res 317, 620\u2013631 (2011).","journal-title":"Exp Cell Res"},{"key":"68921_CR29","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M. et al. Infiltrating CD8(+) T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci 26, 1489\u20131504 (2023).","journal-title":"Nat Neurosci"},{"key":"68921_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-024-00726-8","volume":"19","author":"L van Olst","year":"2024","unstructured":"van Olst, L. et al. Adaptive immune changes associate with clinical progression of Alzheimer\u2019s disease. Mol Neurodegener 19, 38 (2024).","journal-title":"Mol Neurodegener"},{"key":"68921_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"68921_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri2959","volume":"11","author":"AN Akbar","year":"2011","unstructured":"Akbar, A. N. & Henson, S. M. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?. Nat Rev Immunol 11, 289\u2013295 (2011).","journal-title":"Nat Rev Immunol"},{"key":"68921_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.coi.2012.04.001","volume":"24","author":"SM Henson","year":"2012","unstructured":"Henson, S. M., Riddell, N. E. & Akbar, A. N. Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol 24, 476\u2013481 (2012).","journal-title":"Curr Opin Immunol"},{"key":"68921_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/ni.3483","volume":"17","author":"V Pulko","year":"2016","unstructured":"Pulko, V. et al. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses. Nat Immunol 17, 966\u2013975 (2016).","journal-title":"Nat Immunol"},{"key":"68921_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.immuni.2016.09.015","volume":"45","author":"S Ranasinghe","year":"2016","unstructured":"Ranasinghe, S. et al. Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion. Immunity 45, 917\u2013930 (2016).","journal-title":"Immunity"},{"key":"68921_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03243-7","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Clonally diverse CD38(+)HLA-DR(+)CD8(+) T cells persist during fatal H7N9 disease. Nat Commun 9, 824 (2018).","journal-title":"Nat Commun"},{"key":"68921_CR37","doi-asserted-by":"publisher","first-page":"113452","DOI":"10.1016\/j.celrep.2023.113452","volume":"42","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. MHC class II regulation of CD8(+) T cell tolerance and implications in autoimmunity and cancer immunotherapy. Cell Rep 42, 113452 (2023).","journal-title":"Cell Rep"},{"key":"68921_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neuron.2024.01.013","volume":"112","author":"A Ramakrishnan","year":"2024","unstructured":"Ramakrishnan, A. et al. Epigenetic dysregulation in Alzheimer\u2019s disease peripheral immunity. Neuron 112, 1235\u20131248 e1235 (2024).","journal-title":"Neuron"},{"key":"68921_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","volume":"134","author":"GP van Nierop","year":"2017","unstructured":"van Nierop, G. P. et al. Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol 134, 383\u2013401 (2017).","journal-title":"Acta Neuropathol"},{"key":"68921_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07053-9","volume":"9","author":"J Smolders","year":"2018","unstructured":"Smolders, J. et al. Tissue-resident memory T cells populate the human brain. Nat Commun 9, 4593 (2018).","journal-title":"Nat Commun"},{"key":"68921_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13024-024-00758-0","volume":"19","author":"X Taylor","year":"2024","unstructured":"Taylor, X. et al. Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 19, 77 (2024).","journal-title":"Mol Neurodegener"},{"key":"68921_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross, C. C. et al. CD8(+) T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun 10, 5779 (2019).","journal-title":"Nat Commun"},{"key":"68921_CR43","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni.2714","volume":"14","author":"AL Doedens","year":"2013","unstructured":"Doedens, A. L. et al. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 14, 1173\u20131182 (2013).","journal-title":"Nat Immunol"},{"key":"68921_CR44","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-021-00601-3","volume":"21","author":"EL Pearce","year":"2021","unstructured":"Pearce, E. L. Metabolism as a driver of immunity. Nat Rev Immunol 21, 618\u2013619 (2021).","journal-title":"Nat Rev Immunol"},{"key":"68921_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633\u2013643 (2013).","journal-title":"Immunity"},{"key":"68921_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12979-024-00443-2","volume":"21","author":"E Winford","year":"2024","unstructured":"Winford, E. et al. Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort. Immun Ageing 21, 36 (2024).","journal-title":"Immun Ageing"},{"key":"68921_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.it.2014.12.004","volume":"36","author":"D O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan, D. & Pearce, E. L. Targeting T cell metabolism for therapy. Trends Immunol 36, 71\u201380 (2015).","journal-title":"Trends Immunol"},{"key":"68921_CR48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"68921_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"TA Springer","year":"1994","unstructured":"Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301\u2013314 (1994).","journal-title":"Cell"},{"key":"68921_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89, 207\u2013215 (2011).","journal-title":"Immunol Cell Biol"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68921-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:01:46Z","timestamp":1772672506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68921-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68921"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68921-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Authors have no competing interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2180"}}